Literature DB >> 15695670

Indirect enzyme-linked immunosorbent assay for detection of Brucella melitensis-specific antibodies in goat milk.

N D Funk1, L B Tabatabai, P H Elzer, S D Hagius, B M Martin, L J Hoffman.   

Abstract

Brucella melitensis is the cause of brucellosis in sheep and goats, which often results in abortion. Few cases of B. melitensis infection in goats have occurred in the United States over the last 25 years. However, vigilance must be maintained, as it is for the bovine milk industry, to ensure that brucellosis is not introduced into the U.S. goat population. The objective of this study was to develop a sensitive and specific indirect enzyme-linked immunosorbent assay (iELISA) for the detection of B. melitensis-specific antibodies in goat milk. Brucella salt-extractable protein extract was employed as an antigen, and a horseradish peroxidase-labeled polyclonal anti-goat antibody was used as an anti-species conjugate. Thirteen of 13 (100%) individual infected goat milk samples tested positive and 134 of 134 (100%) uninfected bulk milk samples tested negative by the developed iELISA. Three positive milk samples with high, medium, and low absorbance values were used to simulate one positive animal in an otherwise negative herd. By this estimation, one high-titer animal could be detected in a herd of >1,600 animals. Detection estimates for medium- and low-titer animals were one positive animal per herd of <200 and 50 animals, respectively. Based on this estimation, it is recommended that herds be sampled in groups of 50 animals or less for bulk milk testing. The iELISA developed for this study was found to be sensitive and specific and shows potential for use as a bulk milk test for the detection of B. melitensis-specific antibodies in goat milk.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15695670      PMCID: PMC548038          DOI: 10.1128/JCM.43.2.721-725.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

1.  Brucella melitensis infection discovered in cattle for first time, goats also infected.

Authors:  S C Kahler
Journal:  J Am Vet Med Assoc       Date:  2000-03-01       Impact factor: 1.936

Review 2.  Diagnosis of brucellosis by serology.

Authors:  Klaus Nielsen
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

3.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

4.  Characterization of the caprine model for ruminant brucellosis.

Authors:  P H Elzer; S D Hagius; D S Davis; V G DelVecchio; F M Enright
Journal:  Vet Microbiol       Date:  2002-12-20       Impact factor: 3.293

5.  An epizootic of Brucella melitensis infection in Texas.

Authors:  R D Whiting; B M White; F C Stiles
Journal:  J Am Vet Med Assoc       Date:  1970-12-01       Impact factor: 1.936

6.  Enzyme-linked immunosorbent assay for bovine immunoglobulin subclass-specific response to Brucella abortus lipopolysaccharides.

Authors:  V L Lamb; L M Jones; G G Schurig; D T Berman
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

7.  Isolation and characterization of toxic fractions from Brucella abortus.

Authors:  L B Tabatabai; B L Deyoe; A E Ritchie
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

8.  Specific enzyme-linked immunosorbent assay for detection of bovine antibody to Brucella abortus.

Authors:  L B Tabatabai; B L Deyoe
Journal:  J Clin Microbiol       Date:  1984-08       Impact factor: 5.948

9.  Ethylenediaminetetraacetic acid (disodium salt)-labile bovine immunoglobulin M Fc binding to Brucella abortus: a cause of nonspecific agglutination.

Authors:  K Nielsen; K Stilwell; B Stemshorn; R Duncan
Journal:  J Clin Microbiol       Date:  1981-07       Impact factor: 5.948

10.  Demonstration that nonspecific bovine Brucella abortus agglutinin is EDTA-labile and not calcium-dependent.

Authors:  K Nielsen; J R Duncan
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.